Evidence map›Paper›PMID 29108254›Full record

ArticleOncotarget2017

The impacts of genetic polymorphisms in genes of base excision repair pathway on the efficacy and acute toxicities of (chemo)radiotherapy in patients with nasopharyngeal carcinoma.

Jing Wang, Chengxian Guo, Xiaochang Gong, Fan Ao, Yuling Huang, Lihua Huang, Yiqiang Tang, Chunling Jiang, Xiaoxue Xie, Qing Dong and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Radiation-induced skin injury in the head and neck region: pathogenesis, clinics, prevention, treatment considerations and proposal for management algorithm.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. MUTYH: Not just polyposis.World journal of clinical oncology · 2020
    Review
  16. Article
  17. Article
  18. Association between NF-BioMed research international · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jing WangDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Chengxian GuoCenter of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Xiaochang GongDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Fan AoDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Yuling HuangDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Lihua HuangCenter for Medical Experiments, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Yiqiang TangDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Chunling JiangDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Xiaoxue XieDepartment of Radiation and Oncology, Hunan Provincial Tumor Hospital and Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha 410013, China.
Qing DongDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Min HuangDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Jingao LiDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang 330029, China.
Jiangxi Provincial Cancer Hospital · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo explore whether polymorphisms in base excision repair (BER) pathway genes are predictors of (chemo)radiotherapy outcome in patients with nasopharyngeal carcinoma (NPC).

methodsWe genotyped five potentially functional single nucleotide polymorphisms (SNPs) of three genes in the BER pathway in 174 NPC patients who were treated with (chemo)radiotherapy. Sequenom MassArray was used for SNPs analysis. The efficacy at the end of radiotherapy and at 3 months after radiotherapy was evaluated by Response Evaluation Criteria in Solid Tumors (RECIST). Acute radiation toxicity was scored using Radiation Therapy Oncology Group and the European Organization for Research and Treatment of Cancer (RTOG/EORTC) acute radiation morbidity scoring criteria. Logistic regression was employed to assess the multivariate analyses.

resultsWe found that the wide genotype GG of X-ray repair cross-complementing 1 (

conclusionsThe SNPs of the BER genes may act as biomarkers for the curative effect of (chemo)radiotherapy. Further study with long-time follow-up and large population is needed for accurate assessment.

Indexed as

acute radiation toxicitybase excision repair (BER) genesnasopharyngeal carcinoma (NPC)short-term efficacysingle nucleotide polymorphism (SNP)

Identifiers

PMID29108254
PMCPMC5667987
OpenAlexW2745182406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.